Good Clinical, Laboratory and Manufacturing Practices

Dr Carson trained as an organic chemist (PhD) and safety and health expert (MSc). He was formally employed by Unilever as research scientist and Head of Science Support Services at their Research and Development Laboratory, Port Sunlight. Responsibilities included, occupational health, safety and environment; consumer safety; ethics of animal and human testing; Quality Assurance (GCP,GLP, GMP, ISO 14001/17025/OHSAS 18001); Project Risk Management and member of the Management Committee. Current posts include Quality Director (4-Front Research Ltd), a H&S consultant, Chairman of CIREC (a research ethics committee recognised for reviewing Phase 1 studies on healthy human volunteers) and member of a local hospital clinical ethics committees. Since 1983 he has been a member of the Institution of Chemical Engineers 'Loss Prevetion Panel' and is a member of the Association of Reserach Ethics Committee. He is past member of the Chemical Industries Association Health Advisory Group and past Chairman of their Hygiene Working Group. Bewteen 1990-2000 he was visiting lecturer in chemistry at UMIST and was PhD examiner for Aston University Chemical Engineering Department. He has over 60 technical publications including The Safe Handling of Chemicals in Industry (3 volumes), Longman The Hazardous Chemicals Handbook (2 editions), Butterworth Heinemann Good Clinical, Laboratory and Manufacturing Practices (2 editions), Royal Society of Chemistry He is also coauthor of 'Silver Screens of Wirral' (2 volumes), Countyvise Ltd

"This book should be essential reading for all those working QA"

• Chapter 1: Introduction to Part 1 - GCP;Chapter 2: The Protocol, Case Report Form & Initial Documentation - Quality Assurance Involvement & Common Problems;Chapter 3: Standard Operating Procedures in the GCP Environment;Chapter 4: Preparing for Regulatory Inspections of Company Pharmacovigilance Systems & Practices in the European Union & United States;Chapter 5: Investigator, Sponsor & Contract Research Organisation Audits;Chapter 6: Data Audits;Chapter 7: Research Ethics Committees;Chapter 8: GCP/GMP Interface, Investigational Product Accountability;Chapter 9: Monitoring & Quality Control;Chapter 10: Phase I Healthy Volunteer Studies;Chapter 11: Clinical Laboratories;Chapter 12: Introduction to Part 2 - Good Laboratory Practice;Chapter 13: Quality Assurance in GLP;Chapter 14: The Master Schedule Index;Chapter 15: Study Plans & Their Audits;Chapter 16: SOPs for GLP Work;Chapter 17: Inspections - Procedural, Process & Facility;Chapter 18: Report and Data Audits;Chapter 19: Quality Assurance & Contract Research Organisations;Chapter 20: Quality Assurance & Pharmacology;Chapter 21: Application of GLP in Analytical Chemistry;Chapter 22: GLP in Drug Metabolism & Pharmacokinetics;Chapter 23: Issues of Quality in Pathology;Chapter 24: GLP in Eco-toxicology and Field Studies;Chapter 25: Animal Health;Chapter 26: Introduction to Part 3 - Good Manufacturing Practice;Chapter 27: Standard Operating Procedures (Specific to GMP);Chapter 28: Release of Bulk & Filled Finished Product;Chapter 29: Good Manufacturing Practice for Investigational Medicinal Products;Chapter 30: Chemical Analysis;Chapter 31: GMP for Sterile Products;Chapter 32: Statistics for QA Auditors of GLP and GCP Studies;Chapter 33: The Use of Statistics in Research Quality Assurance;Chapter 34: Supplier Auditing (GMP);Chapter 35: Centralised Supplier Audits (GLP);Chapter 36: Document Control from Concept to Archiving;Chapter 37: Computing & GXP's;Chapter 38: QA Developing A Regulatory Compliance Training Strategy;Chapter 39: Training & Staff Records for GXP;Chapter 40: Integrating Quality Systems (GCP, GLP, GMP, ISO 9000, 14001, 18001 & 17025